Page last updated: 2024-09-05

darunavir and Bilirubinemia

darunavir has been researched along with Bilirubinemia in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (60.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	1 (20.00)	2.80

Authors

Authors	Studies
Chen, HJ; Colletti, L; Degoey, DA; Dekhtyar, T; Flentge, CA; Flosi, WJ; Grampovnik, DJ; Kati, WM; Kempf, DJ; Klein, LL; Mamo, M; Marsh, KC; Mo, H; Molla, A; Morfitt, DC; Nguyen, B; Randolph, JT; Schmidt, JM; Stoll, V; Swanson, SJ; Yeung, CM	1
Chan, WW; Li, M; Zucker, SD	1
Bernardino, JI; Carton, JA; Curran, A; Domingo, P; Ferrer, E; Gatell, JM; Gonzalez-Cordon, A; Gutierrez, F; Martinez, E; Murillas, J; Negredo, E; Peraire, J; Perez, I; Pich, J; Podzamczer, D; Portilla, J; Santos, I	1
Camacho, A; Pérez-Camacho, I; Rivero, A; Torre-Cisneros, J	1
De Marez, T; De Paepe, E; De Pauw, M; Hoetelmans, RM; Lefebvre, E; Sekar, VJ; Spinosa-Guzman, S; Vangeneugden, T	1

Reviews

1 review(s) available for darunavir and Bilirubinemia

Article	Year
[Darunavir in HIV/HVC/HVB coinfection]. Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 10 Topics: Adult; Antiretroviral Therapy, Highly Active; Antiviral Agents; Chemical and Drug Induced Liver Injury; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Darunavir; Dose-Response Relationship, Drug; Drug Interactions; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Hyperbilirubinemia; Inactivation, Metabolic; Liver; Liver Cirrhosis; Male; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Sulfonamides	2008

Article

Year

[Darunavir in HIV/HVC/HVB coinfection].

Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 10

Topics: Adult; Antiretroviral Therapy, Highly Active; Antiviral Agents; Chemical and Drug Induced Liver Injury; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Darunavir; Dose-Response Relationship, Drug; Drug Interactions; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Hyperbilirubinemia; Inactivation, Metabolic; Liver; Liver Cirrhosis; Male; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Sulfonamides

2008

Trials

2 trial(s) available for darunavir and Bilirubinemia

Article	Year
Early lipid changes with atazanavir/ritonavir or darunavir/ritonavir. HIV medicine, 2014, Volume: 15, Issue:6 Topics: Adult; Atazanavir Sulfate; Bilirubin; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Darunavir; Drug Therapy, Combination; Female; Glomerular Filtration Rate; HIV Infections; HIV Protease Inhibitors; Humans; Hyperbilirubinemia; Lipids; Male; Middle Aged; Oligopeptides; Prospective Studies; Pyridines; Ritonavir; RNA, Viral; Spain; Sulfonamides	2014
Pharmacokinetics of darunavir (TMC114) and atazanavir during coadministration in HIV-negative, healthy volunteers. Drugs in R&D, 2007, Volume: 8, Issue:4 Topics: Adolescent; Adult; Area Under Curve; Atazanavir Sulfate; Chromatography, Liquid; Cross-Over Studies; Darunavir; Dose-Response Relationship, Drug; Drug Interactions; Female; Half-Life; HIV Protease Inhibitors; Humans; Hyperbilirubinemia; Male; Middle Aged; Nausea; Oligopeptides; Pyridines; Sulfonamides; Tandem Mass Spectrometry; Time Factors; Vomiting	2007

Article

Year

Early lipid changes with atazanavir/ritonavir or darunavir/ritonavir.

HIV medicine, 2014, Volume: 15, Issue:6

Topics: Adult; Atazanavir Sulfate; Bilirubin; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Darunavir; Drug Therapy, Combination; Female; Glomerular Filtration Rate; HIV Infections; HIV Protease Inhibitors; Humans; Hyperbilirubinemia; Lipids; Male; Middle Aged; Oligopeptides; Prospective Studies; Pyridines; Ritonavir; RNA, Viral; Spain; Sulfonamides

2014

Pharmacokinetics of darunavir (TMC114) and atazanavir during coadministration in HIV-negative, healthy volunteers.

Drugs in R&D, 2007, Volume: 8, Issue:4

Topics: Adolescent; Adult; Area Under Curve; Atazanavir Sulfate; Chromatography, Liquid; Cross-Over Studies; Darunavir; Dose-Response Relationship, Drug; Drug Interactions; Female; Half-Life; HIV Protease Inhibitors; Humans; Hyperbilirubinemia; Male; Middle Aged; Nausea; Oligopeptides; Pyridines; Sulfonamides; Tandem Mass Spectrometry; Time Factors; Vomiting

2007

Other Studies

2 other study(ies) available for darunavir and Bilirubinemia

Article	Year
2-Pyridyl P1'-substituted symmetry-based human immunodeficiency virus protease inhibitors (A-792611 and A-790742) with potential for convenient dosing and reduced side effects. Journal of medicinal chemistry, 2009, Apr-23, Volume: 52, Issue:8 Topics: Animals; Binding Sites; Biological Availability; Caco-2 Cells; Carbamates; Cell Membrane Permeability; Crystallography, X-Ray; Dipeptides; Dogs; Drug Resistance, Viral; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Hyperbilirubinemia; Hyperlipidemias; In Vitro Techniques; Microsomes, Liver; Models, Molecular; Mutation; Putrescine; Pyridines; Rats; Rats, Gunn; Stereoisomerism; Structure-Activity Relationship	2009
Association Between Atazanavir-Induced Hyperbilirubinemia and Cardiovascular Disease in Patients Infected with HIV. Journal of the American Heart Association, 2020, 10-20, Volume: 9, Issue:19 Topics: Atazanavir Sulfate; Bilirubin; Cardiovascular Diseases; Darunavir; Female; HIV Infections; HIV Protease Inhibitors; Humans; Hyperbilirubinemia; Ischemic Stroke; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Retrospective Studies; Time Factors	2020

Article

Year

2-Pyridyl P1'-substituted symmetry-based human immunodeficiency virus protease inhibitors (A-792611 and A-790742) with potential for convenient dosing and reduced side effects.

Journal of medicinal chemistry, 2009, Apr-23, Volume: 52, Issue:8

Topics: Animals; Binding Sites; Biological Availability; Caco-2 Cells; Carbamates; Cell Membrane Permeability; Crystallography, X-Ray; Dipeptides; Dogs; Drug Resistance, Viral; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Hyperbilirubinemia; Hyperlipidemias; In Vitro Techniques; Microsomes, Liver; Models, Molecular; Mutation; Putrescine; Pyridines; Rats; Rats, Gunn; Stereoisomerism; Structure-Activity Relationship

2009

Association Between Atazanavir-Induced Hyperbilirubinemia and Cardiovascular Disease in Patients Infected with HIV.

Journal of the American Heart Association, 2020, 10-20, Volume: 9, Issue:19

Topics: Atazanavir Sulfate; Bilirubin; Cardiovascular Diseases; Darunavir; Female; HIV Infections; HIV Protease Inhibitors; Humans; Hyperbilirubinemia; Ischemic Stroke; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Retrospective Studies; Time Factors

2020